Breaking News Headlines Today

News about Johnson & Johnson

Stay current with all the latest and breaking news about Johnson & Johnson, compare headlines and perspectives between news sources on stories happening today. In total, 79 stories have been published about Johnson & Johnson which Ground News has aggregated in the past 3 months.

Covered Most By

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

News about Johnson & Johnson

News about Johnson & Johnson

Covered Most By

Local News Publishers

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Johnson & Johnson

Pfizer, J&J sued by New Jersey over decades-old pharmaceutical plant pollution

Notable analyst calls this week: J&J, PayPal and Corteva among top picks (NYSE:JNJ)

Who's building new pharma factories and who might be spared from 100% tariffs

This IBD 50 Stock, Up 90% In 2025, Is Winning Against Cancer

NJ Sues Pfizer Over Cancer-Linked Water Contamination - Inside Climate News

EGFR Lung Cancer 2025: AstraZeneca’s Tagrisso vs J&J’s Rybrevant in Global Trials Highlight Efficacy and Tolerability Trade-Offs

J&J's Bladder Cancer Development Leader Who Secured FDA Approval Joins enGene as Chief Medical Officer

Science for Health 2025: Stronger Regions, Greater Impact

First-Ever IL-23 Inhibitor: J&J's TREMFYA Approved for Children with Psoriasis, Shows 56% Clearance Rate

The 13 Spanish Directors Who Drive the World: "They Are Agile in Turbulent Environments Like the Current One"

Pfizer, J&J sued by New Jersey over decades-old pharmaceutical plant pollution

Notable analyst calls this week: J&J, PayPal and Corteva among top picks (NYSE:JNJ)

Who's building new pharma factories and who might be spared from 100% tariffs

This IBD 50 Stock, Up 90% In 2025, Is Winning Against Cancer

NJ Sues Pfizer Over Cancer-Linked Water Contamination - Inside Climate News

EGFR Lung Cancer 2025: AstraZeneca’s Tagrisso vs J&J’s Rybrevant in Global Trials Highlight Efficacy and Tolerability Trade-Offs

J&J's Bladder Cancer Development Leader Who Secured FDA Approval Joins enGene as Chief Medical Officer

Science for Health 2025: Stronger Regions, Greater Impact

First-Ever IL-23 Inhibitor: J&J's TREMFYA Approved for Children with Psoriasis, Shows 56% Clearance Rate

The 13 Spanish Directors Who Drive the World: "They Are Agile in Turbulent Environments Like the Current One"